🔎 Trials Near Me

Home › Bladder Cancer › Nevada

Bladder Cancer clinical trials in Nevada

6 studies for Bladder Cancer are looking for participants at sites in Nevada.

Cities in Nevada

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Carson Tahoe Regional Medical Center, Carson City
  • Comprehensive Cancer Centers of Nevada - Henderson, Henderson
  • Comprehensive Cancer Centers of Nevada-Horizon Ridge, Henderson
  • and 24 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Nov 4, 2026 · NCT05334069

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

  • Comprehensive Cancer Centers of Nevada - Southwest, Las Vegas
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07566156

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

  • Renown Regional Medical Center, Reno
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 23, 2026 · NCT07097142

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  • Comprehensive Cancer Centers of Nevada, Las Vegas
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT07218380

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

  • Renown Regional Medical Center, Reno
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07000084

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

  • Comprehensive Cancer Centers of Nevada, Las Vegas
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 6, 2026 · NCT04389632

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.